iSpecimen Inc. APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition
iSpecimen Inc. (ISPC) reported APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition of $153 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital › APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition · last filed 2026-08-14
- iSpecimen Inc. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2026-06-30 was $153.00.
- iSpecimen Inc. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2026-03-31 was $153.00, a 86.79% decline year-over-year.
- iSpecimen Inc. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2025-09-30 was $94.00, a 99.54% decline year-over-year.
- iSpecimen Inc. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2025-06-30 was -$66.00, a 100.19% decline year-over-year.
- iSpecimen Inc. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2025 was $1.34K, a 98.69% decline from fiscal 2024.
- iSpecimen Inc. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2024 was $101.84K.
| Period end | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $153.00 10-Q · filed 2026-08-14 | $306.00 derived: sum of 2 quarters · filed 2026-08-14 | ||
| 2026-03-31 | $153.00 10-Q · filed 2026-08-14 | |||
| 2025-12-31 | $1.34K 10-K · filed 2026-04-01 | |||
| 2025-09-30 | $94.00 10-Q · filed 2025-11-17 | $28.00 derived: sum of 2 quarters · filed 2025-11-17 | $1.19K derived: sum of 3 quarters · filed 2026-08-14 | |
| 2025-06-30 | -$66.00 10-Q · filed 2025-11-17 | $1.09K derived: sum of 2 quarters · filed 2026-08-14 | ||
| 2025-03-31 | $1.16K 10-Q · filed 2026-08-14 | |||
| 2024-12-31 | $101.84K 10-K · filed 2026-04-01 | |||
| 2024-09-30 | $20.30K 10-Q · filed 2025-11-17 | $55.14K derived: sum of 2 quarters · filed 2025-11-17 | $101.01K derived: sum of 3 quarters · filed 2025-11-17 | |
| 2024-06-30 | $34.83K 10-Q · filed 2025-11-17 | $80.70K derived: sum of 2 quarters · filed 2025-11-17 | ||
| 2024-03-31 | $45.87K 10-Q · filed 2025-11-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |